Double-sided printing system for continuous forms
    2.
    发明授权
    Double-sided printing system for continuous forms 失效
    双面打印系统,可连续使用

    公开(公告)号:US5548390A

    公开(公告)日:1996-08-20

    申请号:US353126

    申请日:1994-12-09

    摘要: An intermediate buffer device for absorbing the difference in paper feeding speed between first and second printers is disposed therebetween. The first printer prints on a first surface of continuous forms in accordance with the top-surface printing data input from a host apparatus, and the second printer prints on the second surface of continuous forms in accordance with the back-surface printing data input from a host apparatus. A detecting portion detects the amount of retention in the intermediate buffer device. A printer controller stops printing and paper feeding by the second printer when the amount of retention falls below a first set value L1 and stops paper feeding and printing by the first printer when the amount of retention exceeds a second set value L2.

    摘要翻译: 用于吸收第一和第二打印机之间的送纸速度差的中间缓冲装置设置在它们之间。 第一打印机根据从主机设备输入的顶表面打印数据在连续形式的第一表面上打印,并且第二打印机根据从主机设备输入的背面打印数据在连续形式的第二表面上打印 主机。 检测部分检测中间缓冲装置中的保持量。 当保持量低于第一设定值L1时,打印机控制器停止第二打印机的打印和进纸,并且当保持量超过第二设定值L2时,停止第一打印机的供纸和打印。

    Imidazo[1,2-b]pyridazine compound
    6.
    发明授权
    Imidazo[1,2-b]pyridazine compound 失效
    咪唑并[1,2-b]哒嗪化合物

    公开(公告)号:US07078405B2

    公开(公告)日:2006-07-18

    申请号:US10451741

    申请日:2002-02-08

    CPC分类号: C07D471/04 C07D487/04

    摘要: The present invention provides a novel compound having an excellent corticotrophin-releasing-factor receptor antagonistic activity. That is, it provides a compound represented by the following formula or a salt thereof. Wherein R1 denotes a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group and the like; R2 denotes a halogen atom, a cyano group, a nitro group, a C1-10 alkyl group, a C2-10 alkenyl group, C2-10 alkynyl group and the like; R3 denotes a C6-14 aromatic hydrocarbon cyclic group or a 5- to 14-membered aromatic heterocyclic group, each of which may have a substituent; and X, Y and X are independent of each other and each denotes N or CR4 (wherein R4 denotes a hydrogen atom, a halogen atom, a cyano group, a nitro group, an optionally halogenated C1-6 alkyl group and the like) and, in this case, at least two of X, Y and Z denote CR4.

    摘要翻译: 本发明提供具有优异的促肾上腺皮质激素释放因子受体拮抗活性的新型化合物。 也就是说,它提供由下式表示的化合物或其盐。 其中R 1表示氢原子,C 1-6烷基,C 1-6烷氧基等; R 2表示卤素原子,氰基,硝基,C 1-10烷基,C 2-10链烯基 基团,C 2-10炔基等; R 3表示可以具有取代基的C 6-14芳族烃环基或5〜14元芳香族杂环基, 并且X,Y和X彼此独立并且各自表示N或CR 4(其中R 4表示氢原子,卤素原子,氰基, 硝基,任选卤代的C 1-6烷基等),在这种情况下,X,Y和Z中的至少两个表示CR 4。